Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to 0.44.

  • Amphastar Pharmaceuticals' Asset Utilization Ratio fell 7.49% to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year decrease of 7.49%. This contributed to the annual value of 0.47 for FY2024, which is 17.12% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.44 for Q3 2025, which was down 1.13% from 0.45 recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Asset Utilization Ratio peaked at 0.68 during Q1 2023, and registered a low of 0.41 during Q3 2023.
  • Its 3-year average for Asset Utilization Ratio is 0.47, with a median of 0.46 in 2025.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Asset Utilization Ratio climbed by 17.73% in 2021 and then slumped by 38.46% in 2023.
  • Amphastar Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.66 in 2021, then grew by 2.69% to 0.68 in 2022, then tumbled by 37.97% to 0.42 in 2023, then increased by 11.22% to 0.47 in 2024, then decreased by 7.49% to 0.44 in 2025.
  • Its Asset Utilization Ratio stands at 0.44 for Q3 2025, versus 0.45 for Q2 2025 and 0.46 for Q1 2025.